Cargando…
Fatal Immune Checkpoint Inhibitor-related Pancreatitis
We herein report a case of fatal pancreatitis induced by an immune checkpoint inhibitor. A 62-year-old man with cancer of unknown primary was treated with pembrolizumab. After 12 cycles, immune-related pneumonitis developed and was treated with prednisolone. Three months later, pancreatitis develope...
Autores principales: | Ueno, Masayuki, Tsuji, Yoshihisa, Yokoyama, Toshihide, Koyama, Takashi, Uenishi, Yosuke, Ishida, Etsuji, Mizuno, Motowo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758462/ https://www.ncbi.nlm.nih.gov/pubmed/34121010 http://dx.doi.org/10.2169/internalmedicine.7366-21 |
Ejemplares similares
-
Two Types of Immune Checkpoint Inhibitor-related Pancreatitis
por: Ichiki, Tomoko, et al.
Publicado: (2021) -
Mycophenolate mofetil for immune checkpoint inhibitor‐related hepatotoxicity relapsing during dose reduction of corticosteroid: A report of two cases and literature review
por: Ueno, Masayuki, et al.
Publicado: (2022) -
Fatal myositis and spontaneous haematoma induced by combined immune checkpoint inhibitor treatment in a patient with pancreatic adenocarcinoma
por: Liu, Yuan, et al.
Publicado: (2019) -
Hypothyroidism as an immune-related adverse event caused by atezolizumab in a patient with muscle spasms: a case report
por: Kawataki, Masanori, et al.
Publicado: (2022) -
Immune Checkpoint Inhibitor-Induced Polymyositis and Myasthenia Gravis with Fatal Outcome
por: Giglio, Daniel, et al.
Publicado: (2020)